AIM: The aim of the present study was to investigate the pattern of biodegradation of different polyethylene glycol (PEG) hydrogel/RGD-peptide modifications in rats. MATERIAL AND METHODS: Two different hydrogels were employed: (i) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and eight-arm PEG-acrylate, M(n)=2.3 kDa (PEG1); and (ii) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and four-arm PEG-acrylate, M(n)=15 kDa (PEG2). Both PEG1 and PEG2 were either used alone or combined with a nine amino acid cys-RGD peptide (RGD). A non-cross-linked porcine type I and III collagen membrane [BioGide (BG)] served as control. Specimens were randomly allocated in unconnected subcutaneous pouches separated surgically on the back of 60 wistar rats, which were divided into six groups (1, 2, 4, 8, 16, and 24 weeks). Specimens were prepared for histological (tissue integration, foreign body reactions, biodegradation) and immunohistochemical (angiogenesis) analysis. RESULTS: All materials investigated revealed unimpeded and comparable tissue integration without any signs of foreign body reactions. While BG exhibited transmembraneous blood vessel formation at 1 week, all PEG specimens were just surrounded by a well-vascularized connective tissue. The hydrolytic disruption of PEG1 and PEG1/RGD specimens was associated with an ingrowth of blood vessels at 4 weeks. Biodegradation times were highest for PEG1 (24 weeks)>PEG1/RGD (16 weeks)>BG (4 weeks)>PEG2=PEG2/RGD (2 weeks). CONCLUSION: Within the limits of the present study, it was concluded that (i) all materials investigated revealed a high biocompatibility and tissue integration, and (ii) hydrogel biodegradation was dependent on PEG composition.
AIM: The aim of the present study was to investigate the pattern of biodegradation of different polyethylene glycol (PEG) hydrogel/RGD-peptide modifications in rats. MATERIAL AND METHODS: Two different hydrogels were employed: (i) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and eight-arm PEG-acrylate, M(n)=2.3 kDa (PEG1); and (ii) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and four-arm PEG-acrylate, M(n)=15 kDa (PEG2). Both PEG1 and PEG2 were either used alone or combined with a nine amino acid cys-RGD peptide (RGD). A non-cross-linked porcine type I and III collagen membrane [BioGide (BG)] served as control. Specimens were randomly allocated in unconnected subcutaneous pouches separated surgically on the back of 60 wistar rats, which were divided into six groups (1, 2, 4, 8, 16, and 24 weeks). Specimens were prepared for histological (tissue integration, foreign body reactions, biodegradation) and immunohistochemical (angiogenesis) analysis. RESULTS: All materials investigated revealed unimpeded and comparable tissue integration without any signs of foreign body reactions. While BG exhibited transmembraneous blood vessel formation at 1 week, all PEG specimens were just surrounded by a well-vascularized connective tissue. The hydrolytic disruption of PEG1 and PEG1/RGD specimens was associated with an ingrowth of blood vessels at 4 weeks. Biodegradation times were highest for PEG1 (24 weeks)>PEG1/RGD (16 weeks)>BG (4 weeks)>PEG2=PEG2/RGD (2 weeks). CONCLUSION: Within the limits of the present study, it was concluded that (i) all materials investigated revealed a high biocompatibility and tissue integration, and (ii) hydrogel biodegradation was dependent on PEG composition.
Authors: Phillipp Brockmeyer; Katharina Kramer; Sebastian Krohn; Philipp Kauffmann; Corinna Mauth; Michel Dard; Henning Schliephake; Rudolf Matthias Gruber Journal: J Mater Sci Mater Med Date: 2015-06-02 Impact factor: 3.896
Authors: Sandeep S Karajanagi; Roshan Yoganathan; Raffaella Mammucari; Hyoungshin Park; Julian Cox; Steven M Zeitels; Robert Langer; Neil R Foster Journal: Biotechnol Bioeng Date: 2011-03-21 Impact factor: 4.530
Authors: Yiming Li; David Fraser; Jared Mereness; Amy Van Hove; Sayantani Basu; Maureen Newman; Danielle S W Benoit Journal: ACS Appl Bio Mater Date: 2021-11-29
Authors: Xavier Struillou; Mia Rakic; Zahi Badran; Laure Macquigneau; Caroline Colombeix; Paul Pilet; Christian Verner; Olivier Gauthier; Pierre Weiss; Assem Soueidan Journal: J Mater Sci Mater Med Date: 2013-08-03 Impact factor: 3.896